FDA Advisers Back Novavax COVID-19 Shots As New US Option
podcast: CBS Baltimore
Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that's made with a more conventional technology than today's U.S. options.
Publicado con Parlarispa